Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. VRTX
4. WMT
5. RXST
6. SPGI
7. RIVN
8. LMT
9. AGIO
10. BFH

Go back to Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa
Gilead Sciences (NASDAQ: GILD) Delayed: 129.61 --0 (-0%)
Previous Close $129.61    52 Week High $108.63 
Open $129.61    52 Week Low $71.39 
Day High $129.61    P/E 71.61 
Day Low $129.61    EPS $1.81 
Volume 3,414